Experts address COVID-19 vaccine myths, safety evidence, and how to frame the benefits of vaccination in pregnancy.
|Podcasts|July 16, 2020
S1E3: Dr. Emily S. Miller: Placental pathology and MVM evidence
Author(s)Lindsey Carr, Editor
This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Emily S. Miller, with Northwestern Medicine in Chicago.
Advertisement
In this exclusive interview, Dr. Miller shares what may be the most interesting clinical findings to date for the impact of COVID-19 on pregnancy.
In this episode, Dr. Miller discusses evidence of maternal vascular malperfusion (MVM) in her clinical practice and research, plus the impact of socioeconomic status in patients and families affected by the virus.
Watch the
Advertisement
Related to this article
Experts look ahead to new maternal vaccines and how to counsel patients on receiving several in one pregnancy.
Experts discuss common patient concerns about vaccination in pregnancy and strategies to improve uptake.
Experts discuss how obstetric and pediatric clinicians can coordinate to protect newborns.
Experts review ACOG's 2026-27 guidance and the RSV window extension for pregnant and postpartum patients.
On September 9, 2026, certolizumab pegol received FDA Breakthrough Therapy Designation for APS pregnancy; Jane E. Salmon, MD, reviews the IMPACT trial results behind it.
Garima Sharma, MD, outlines validated cardiac risk scores for antenatal screening and the postpartum transitions needed to keep high-risk patients from being lost to follow-up.
Anti-CGRP antibody exposure in early pregnancy was linked to higher spontaneous abortion risk; propranolol was not.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG guideline expands menopause VMS, sleep, and mood recommendations
2
Executive order directs NIH to create women's health division
3
Actigraphy and Objective Sleep Outcomes in Menopause VMS Treatment
4
Organon reports interim phase 3 data for MIUDELLA IUD through 6 years
5